APA (7th ed.) Citation

A, L., V, C., F, P., G, M., P, B., E, B., . . . M, T. (2026). Outcomes of first-line chemo-immunotherapy in advanced non-squamous NSCLC according to KRAS status: An Italian real-world study. Tumori, 112(4), 316. https://doi.org/10.1177/03008916261443123

Chicago Style (17th ed.) Citation

A, Leonetti, et al. "Outcomes of First-line Chemo-immunotherapy in Advanced Non-squamous NSCLC According to KRAS Status: An Italian Real-world Study." Tumori 112, no. 4 (2026): 316. https://doi.org/10.1177/03008916261443123.

MLA (9th ed.) Citation

A, Leonetti, et al. "Outcomes of First-line Chemo-immunotherapy in Advanced Non-squamous NSCLC According to KRAS Status: An Italian Real-world Study." Tumori, vol. 112, no. 4, 2026, p. 316, https://doi.org/10.1177/03008916261443123.